In addition, based on p53 mutational status and HPV infection, we will propose a new classification for HNSCC encompassing 1°) wildtype p53, 2°) mutated p53, and 3°) HPV-positive head and neck carcinomas, related to specific treatment strategies targeting p53 in order to restore its activity. The gene discussed is TP53; the disease is head and neck carcinoma.